Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors |
| |
Authors: | Bayot Aurélien Basse Nicolas Lee Irene Gareil Monique Pirotte Bernard Bulteau Anne-Laure Friguet Bertrand Reboud-Ravaux Michèle |
| |
Institution: | Laboratoire de Biologie et Biochimie Cellulaire du Vieillissement, EA 3106 / IFR 117, Université Paris 7-Denis Diderot, 2 place Jussieu, Tour 33-23, 1(er) étage, CC 7128, 75251 Paris cedex 05, France. |
| |
Abstract: | Cellular protein homeostasis results from the combination of protein biogenesis processes and protein quality control mechanisms, which contribute to the functional state of cells under normal and stress conditions. Proteolysis constitutes the final step by which short-lived, misfolded and damaged intracellular proteins are eliminated. Protein turnover and oxidatively modified protein degradation are mainly achieved by the proteasome in the cytosol and nucleus of eukaryotic cells while several ATP-dependent proteases including the matrix protease Lon take part in the mitochondrial protein degradation. Moreover, Lon protease seems to play a major role in the elimination of oxidatively modified proteins in the mitochondrial matrix. Specific inhibitors are commonly used to assess cellular functions of proteolytic systems as well as to identify their protein substrates. Here, we present and discuss known proteasome and Lon protease inhibitors. To date, very few inhibitors of Lon have been described and no specific inhibitors of this protease are available. The current knowledge on both catalytic mechanisms and inhibitors of these two proteases is first described and attempts to define specific non-peptidic inhibitors of the human Lon protease are presented. |
| |
Keywords: | Proteasome inhibitors Lon protease inhibitors Coumarinic derivatives |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|